dc.creatorRojas, M. Cecilia
dc.creatorUrrutia, Oriana
dc.creatorCruz, Carlos
dc.creatorGaskin, Paul
dc.creatorTudzynski, Bettina
dc.creatorHedden, Peter
dc.date.accessioned2018-12-20T14:10:50Z
dc.date.available2018-12-20T14:10:50Z
dc.date.created2018-12-20T14:10:50Z
dc.date.issued2004
dc.identifierPhytochemistry, Volumen 65, Issue 7, 2018, Pages 821-830
dc.identifier00319422
dc.identifier10.1016/j.phytochem.2004.02.007
dc.identifierhttps://repositorio.uchile.cl/handle/2250/154452
dc.description.abstractThe steps involved in kaurenolide and fujenoic acids biosynthesis, from ent-kauradienoic acid and ent-6α,7α-dihydroxykaurenoic acid, respectively, are demonstrated in the gibberellin (GA)-deficient Gibberella fujikuroi mutant SG139, which lacks the entire GA-biosynthesis gene cluster, complemented with the P450-1 gene of GA biosynthesis (SG139-P450-1). ent-[ 2H]Kauradienoic acid was efficiently converted into 7β-hydroxy[2H]kaurenolide and 7β,18-dihydroxy[ 2H]kaurenolide by the cultures while 7β-hydroxy[ 2H]kaurenolide was transformed into 7β,18-dihydroxy[ 2H]kaurenolide. The limiting step was found to be hydroxylation at C-18. In addition, SG139-P450-1 transformed ent-6α,7α- dihydroxy[14C4]kaurenoic acid into [14C 4]fujenoic acid and [14C4]fujenoic triacid. Fujenal was also converted into the same products but was demonstrated not to be an intermediate in this sequence. All the above reactions were absent in the mutant SG139 and were suppressed in the wild-type strain ACC917 by disrupt
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourcePhytochemistry
dc.subjectBiosynthesis
dc.subjectGibberella fujikuroi
dc.subjectKaurenolide and fujenoic acids
dc.subjectP450 monooxygenases
dc.titleKaurenolides and fujenoic acids are side products of the gibberellin P450-1 monooxygenase in Gibberella fujikuroi
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución